Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Frontiers in Neuroanatomy|October 12, 2020
Corrigendum: Perivascular Unit: This Must Be the Place. The Anatomical Crossroad Between the Immune, Vascular and Nervous SystemFernanda Troili, Virginia Cipollini, Marco Moci, et al.
Journal of Translational Medicine|November 23, 2012
Fc gamma receptor IIIa polymorphisms in advanced colorectal cancer patients correlated with response to anti-EGFR antibodies and clinical outcomeRosa Calemma, Alessandro Ottaiano, Anna Maria Trotta, et al.
Frontiers in Neurology|May 24, 2021
Circulating hsa-miR-323b-3p in Huntington's Disease: A Pilot StudyMichela Ferraldeschi, Silvia Romano, Simona Giglio, et al.
International Journal of Molecular Sciences|April 30, 2021
A Case of Double Standard: Sex Differences in Multiple Sclerosis Risk FactorsBenedetta Angeloni, Rachele Bigi, Gianmarco Bellucci, et al.
Frontiers in Oncology|February 23, 2023
Heterogeneous disease and intermittent treatment in metastatic colorectal cancer: A case reportAlfonso De Stefano, Nicoletta Zanaletti, Antonino Cassata, et al.
Cancer Reports (Hoboken, N.J.)|March 27, 2026
Does Curative Radiotherapy Impact Fatigue Onset in Prostate Cancer Patients? An Analysis of 1253 PatientsMilena Ferro, Savino Cilla, Gabriella Macchia, et al.
The British Journal of Radiology|April 22, 2022
A SHort course Accelerated RadiatiON therapy (SHARON) dose-escalation trial in older adults head and neck non-melanoma skin cancerMilena Ferro, Francesco Deodato, Marica Ferro, et al.
American Journal of Clinical Oncology|February 8, 2006
Capecitabine plus weekly oxaliplatin in gastrointestinal tumors: a phase I studyChiara Carlomagno, Michele Orditura, Stefano Pepe, et al.
Frontiers in Pharmacology|May 19, 2018
First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-AnalysisAlessandro Ottaiano, Alfonso De Stefano, Monica Capozzi, et al.
Cancer Immunology Research|January 29, 2016
Prospective Evaluation of Cetuximab-Mediated Antibody-Dependent Cell Cytotoxicity in Metastatic Colorectal Cancer Patients Predicts Treatment EfficacyAnna Maria Trotta, Alessandro Ottaiano, Carmela Romano, et al.
Pageof 9